77 related articles for article (PubMed ID: 34276692)
1. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide from Gut-Associated Lymphoid-Tissue-Resident Alcaligenes faecalis: Complete Structure Determination and Chemical Synthesis of Its Lipid A.
Shimoyama A; Di Lorenzo F; Yamaura H; Mizote K; Palmigiano A; Pither MD; Speciale I; Uto T; Masui S; Sturiale L; Garozzo D; Hosomi K; Shibata N; Kabayama K; Fujimoto Y; Silipo A; Kunisawa J; Kiyono H; Molinaro A; Fukase K
Angew Chem Int Ed Engl; 2021 Apr; 60(18):10023-10031. PubMed ID: 33522128
[TBL] [Abstract][Full Text] [Related]
3. Application of phosphorylcholine derivative as mucosal adjuvant enhancing mucosal immune responses in the upper respiratory tract.
Jimura T; Kurono Y; Hirano T; Kawabata M; Yamashita M
Auris Nasus Larynx; 2024 Feb; 51(1):221-229. PubMed ID: 37532644
[TBL] [Abstract][Full Text] [Related]
4. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity.
Fukuiwa T; Sekine S; Kobayashi R; Suzuki H; Kataoka K; Gilbert RS; Kurono Y; Boyaka PN; Krieg AM; McGhee JR; Fujihashi K
Vaccine; 2008 Sep; 26(37):4849-59. PubMed ID: 18625280
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of chitosan-based emulsion as an adjuvant to enhance nasal mucosal immune responses.
Li D; Li W; Li S; Zhang Y; Hu X; Liu S; Li Y
Int J Biol Macromol; 2024 Jun; 272(Pt 2):132913. PubMed ID: 38851606
[TBL] [Abstract][Full Text] [Related]
6. Migratory CD103
Gribonika I; Strömberg A; Chandode RK; Schön K; Lahl K; Bemark M; Lycke N
Mucosal Immunol; 2024 Mar; ():. PubMed ID: 38492746
[TBL] [Abstract][Full Text] [Related]
7. A rat model of adenoid hypertrophy constructed by using ovalbumin and lipopolysaccharides to induce allergy, chronic inflammation, and chronic intermittent hypoxia.
Liu A; Zhang Y; Lin Y; Li X; Wang S; Pu W; Liu X; Jiang Z; Xiao Z
Animal Model Exp Med; 2024 Apr; ():. PubMed ID: 38572767
[TBL] [Abstract][Full Text] [Related]
8. Polymeric Caffeic Acid Acts as an Antigen Delivery Carrier for Mucosal Vaccine Formulation by Forming a Complex with an Antigenic Protein.
Tada R; Nagai Y; Ogasawara M; Saito M; Ohshima A; Yamanaka D; Kunisawa J; Adachi Y; Negishi Y
Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793700
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant.
Kim KS; Kim H; Park Y; Kong WH; Lee SW; Kwok SJ; Hahn SK; Yun SH
Adv Funct Mater; 2016 Apr; 26(15):2512-2522. PubMed ID: 27833475
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Chemical Synthesis of Structural Domains of Lipopolysaccharides from the Commensal Gut-Associated Microbiota.
Wang X; Xiao G
Chembiochem; 2023 Dec; 24(23):e202300552. PubMed ID: 37731010
[TBL] [Abstract][Full Text] [Related]
11. The construction of
Yang X; Chen X; Lei T; Qin L; Zhou Y; Hu C; Liu Q; Gao H
Acta Pharm Sin B; 2020 Jun; 10(6):1094-1105. PubMed ID: 32642415
[TBL] [Abstract][Full Text] [Related]
12. Fusion of parvovirus B19 receptor-binding domain and pneumococcal surface protein A induces protective immunity against parvovirus B19 and Streptococcus pneumoniae.
Suzuki H; Noguchi T; Ogawa K; Miyazato P; Hatakeyama Y; Morita E; Ebina H
Vaccine; 2021 Aug; 39(36):5146-5152. PubMed ID: 34340860
[TBL] [Abstract][Full Text] [Related]
13. Alcaligenes lipid A functions as a superior mucosal adjuvant to monophosphoryl lipid A via the recruitment and activation of CD11b+ dendritic cells in nasal tissue.
Sun X; Hosomi K; Shimoyama A; Yoshii K; Saika A; Yamaura H; Nagatake T; Kiyono H; Fukase K; Kunisawa J
Int Immunol; 2024 Jan; 36(1):33-43. PubMed ID: 38006376
[TBL] [Abstract][Full Text] [Related]
14. The Respiratory Commensal Bacterium
Ortiz Moyano R; Raya Tonetti F; Fukuyama K; Elean M; Tomokiyo M; Suda Y; Melnikov V; Kitazawa H; Villena J
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992195
[TBL] [Abstract][Full Text] [Related]
15. ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection.
Arabpour M; Lebrero-Fernandez C; Schön K; Strömberg A; Börjesson V; Lahl K; Ballegeer M; Saelens X; Angeletti D; Agace W; Lycke N
Mucosal Immunol; 2022 Apr; 15(4):745-761. PubMed ID: 35418673
[TBL] [Abstract][Full Text] [Related]
16. Chemically Synthesized
Liu Z; Hosomi K; Shimoyama A; Yoshii K; Sun X; Lan H; Wang Y; Yamaura H; Kenneth D; Saika A; Nagatake T; Kiyono H; Fukase K; Kunisawa J
Front Pharmacol; 2021; 12():763657. PubMed ID: 34744743
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide Derived From the Lymphoid-Resident Commensal Bacteria
Wang Y; Hosomi K; Shimoyama A; Yoshii K; Nagatake T; Fujimoto Y; Kiyono H; Fukase K; Kunisawa J
Front Immunol; 2021; 12():699349. PubMed ID: 34276692
[No Abstract] [Full Text] [Related]
18. Adjuvant Activity of Synthetic Lipid A of
Wang Y; Hosomi K; Shimoyama A; Yoshii K; Yamaura H; Nagatake T; Nishino T; Kiyono H; Fukase K; Kunisawa J
Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32698404
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
